Five Swiss services with published addiction and co-occurring mental health treatment are THE BALANCE, CALDA Clinic, NEOVIVA, Psychiatrische Dienste Aargau, and Arud. They serve different needs: private residential care, specialist hospital treatment, and outpatient addiction psychiatry. The best choice depends on the combination of conditions, present stability, and whether the service can coordinate the necessary treatment in the appropriate setting.
This comparison was checked on October 17, 2026. It includes premium private options and specialist services without calling every setting luxury. The order is not an outcome ranking. Each entry has a direct official source so readers can distinguish documented clinical scope from questions that still require an individual admission assessment.
Look for one coordinated plan, not two disconnected services
Dual diagnosis usually refers to a substance use disorder occurring with another mental disorder. It does not specify the actual combination, severity, or treatment setting. Alcohol use with depression creates different decisions from opioid dependence with psychosis, or sedative dependence with panic symptoms. A provider needs to understand that particular combination before deciding whether its program is suitable.
The National Institute of Mental Health explains that mental health and substance use problems can share contributing factors, influence one another, and produce overlapping symptoms. A comprehensive assessment helps clarify what is happening. It also describes integrated care as coordinated treatment of both concerns, with behavioral treatment, medication when appropriate, and other support organized together.
In practice, integration should be visible in the treatment plan. Ask who combines the substance use history, psychiatric assessment, physical findings, and medication decisions. The answer should identify how clinicians share information and resolve conflicting recommendations. Our guide to integrated dual-diagnosis treatment explains what that coordination can look like during a Swiss episode of care.
| Provider | Published service model | Main distinction to clarify |
|---|---|---|
| THE BALANCE | Private residential care with a dual-diagnosis framework | Current residential suitability and the shared clinical plan |
| CALDA Clinic | Individual residential addiction care addressing co-occurring concerns | Evidence and responsibility for each proposed intervention |
| NEOVIVA | Residential addiction and mental health care in a boutique hotel setting | How partner detoxification and subsequent treatment connect |
| Psychiatrische Dienste Aargau | Specialist inpatient acute addiction and dual-diagnosis treatment | Hospital indication, admission eligibility, and continuing care |
| Arud | Outpatient addiction psychiatry and psychotherapy | Whether outpatient care can meet the person’s present needs |
Five providers with different clinical roles
THE BALANCE: a shared formulation within private residential care
THE BALANCE’s dual-diagnosis page describes bringing psychiatric symptoms, substance use, medication, and life history into a coordinated plan. Its Swiss residential service is in Zurich. This is relevant for someone seeking an individual residential approach whose needs can be managed safely in that model.
The published suitability criteria distinguish residential treatment from needs requiring more intensive or emergency care. Ask which clinician will lead the combined formulation, how the existing prescriber will participate, and what findings would change the proposed setting. Confirm accommodation, professional availability, and treatment inclusions in the written proposal rather than assuming that every private program has the same staffing or arrangements.
CALDA Clinic: individual addiction care with co-occurring assessment
CALDA Clinic describes assessment and individual treatment for addiction, including associated depression, anxiety, trauma, and other concerns. Its team directory identifies psychiatric and medical professionals alongside therapeutic and nutritional roles. Ask which of those professionals will actually participate in the proposed admission.
CALDA’s broad model makes the rationale for the individual plan particularly important. Ask how standard psychiatric and addiction treatment will be delivered, what each additional test or complementary intervention is intended to achieve, and how progress will be evaluated. Co-occurring difficulties should not automatically be reduced to one presumed root cause. Establish how clinically indicated medication is reviewed and continued or changed with the responsible prescriber.
NEOVIVA: connect stabilization with the residential phase
NEOVIVA publishes mental health treatment alongside its addiction service in Vitznau. Its residential model includes individual and group work. The alcohol treatment page describes addressing co-occurring problems and explains that medically supported detoxification may take place through a nearby partner clinic before the residential program.
For a person needing withdrawal care, compare the connection between those phases. Who shares the psychiatric findings, medication changes, and physical observations? Who decides when transfer is appropriate? Ask whether the same clinical formulation follows the patient through the transition, and how a deterioration would be managed. A planned partnership can be useful, but the responsibilities between organizations need to be explicit.
Psychiatrische Dienste Aargau: specialist hospital treatment
Psychiatrische Dienste Aargau describes integrated inpatient addiction and dual-diagnosis treatment at Königsfelden in Windisch for adults aged 18 to 64. Its published scope includes acute addiction-related concerns, serious co-occurring psychiatric illness, withdrawal treatment, and assessment of physical complications. It also describes opioid agonist treatment and coordination of psychiatric or psychotherapeutic follow-up.
This is a specialist hospital pathway, not a luxury residence. It may be a more relevant comparison when someone requires a level of protection or clinical intensity that a private residential setting cannot provide. The referring clinician should confirm the indication, admission route, territorial eligibility, and funding arrangements. An overseas visitor should not assume that publication of a service creates automatic access.
Arud: integrated outpatient psychiatry and addiction care
Arud’s psychiatry and psychotherapy service in Zurich describes comprehensive assessment, shared treatment planning, psychological treatment, and medication when needed. It identifies depression, anxiety, PTSD, and ADHD among the mental health concerns that can accompany substance use. Individual, couple, and family conversations can form part of its work.
Arud provides an outpatient comparison for people whose needs can be managed while they live outside a facility. Ask about assessment access, appointment intensity, crisis arrangements, and the ability to coordinate with an existing physician. It does not provide a residential stay simply because a patient prefers one. Housing, daily functioning, and the ability to attend treatment need consideration alongside the diagnoses themselves.
Test integration with a concrete clinical example
Ask the team to explain how it would approach the actual combination involved. With alcohol use and depression, that includes the timeline of drinking, mood symptoms, previous episodes, sleep, medication, and safety. The plan should allow for symptoms to be reassessed as circumstances change without implying that all distress must be ignored until a fixed period of abstinence has passed.
NIMH emphasizes that overlapping symptoms make comprehensive assessment important. That supports a continuing formulation rather than an immediate certainty about which condition caused the other. Our alcohol and depression guide develops that example. Useful questions include what will be treated now, what remains uncertain, and what observations would lead the team to revise its understanding.
With PTSD and substance use, ask how trauma symptoms, avoidance, sleep, current safety, and the function of substance use will be discussed together. The answer should identify a coherent sequence and the patient’s involvement, rather than promising an identical trauma intervention for everyone. Our PTSD and substance use guide explains the decisions that a personalized assessment needs to address.
Compare the actual responsibilities across professions
Request a clear explanation of who is responsible for psychiatric diagnosis, substance use treatment, physical health, prescribing, and day-to-day observation. Several professionals can contribute without fragmenting care, provided they have a practical way to communicate. Ask how often the plan is reviewed and how the patient can raise conflicting advice or concerns about treatment.
Medication decisions deserve particular clarity. A person may arrive with medicines prescribed for more than one condition and by more than one clinician. Ask who reviews the complete list, who communicates changes, and who will prescribe afterward. Do not make medication changes yourself to meet a facility’s preferences; resolve those questions with the responsible clinicians before admission.
Also ask what happens outside scheduled therapy. A useful answer distinguishes routine support, urgent clinical review, and situations requiring transfer. The service should explain its limits directly. A reassuring environment and frequent contact can be valuable, but neither establishes that a facility can manage every withdrawal complication or acute psychiatric presentation.
Measure change in both conditions and ordinary functioning
Ask the team and patient to identify a small set of meaningful goals at the start. A reduction in substance use does not by itself describe mood, sleep, panic, or the ability to manage daily life. Equally, an improvement in anxiety during a protected stay does not establish that substance-related risks have been addressed. Review each concern and the way the concerns interact.
Those goals can guide practical decisions without becoming a promise of a particular outcome. For example, a review might consider whether the person understands the medication plan, can recognize situations that need help, and has practiced responding to difficulties likely to occur at home. Ask what would happen if one area improves while another worsens. Integrated care should make that discrepancy visible and respond to it, rather than relying on a single favorable overall impression.
Choose a program that can carry both plans home
Compare discharge arrangements as carefully as admission. The receiving clinician needs an understandable account of the working diagnoses, remaining uncertainty, medication changes, response to treatment, and next steps. Ask whether the addiction and mental health plans will be handed over together, with the patient’s consent, rather than arriving as separate recommendations that nobody is responsible for coordinating.
For an international patient, establish which professionals can continue the work at home and whether the proposed follow-up is available in that jurisdiction. Our returning-home guide helps organize that transition. The strongest comparison is the complete pathway: appropriate assessment, a realistic level of care, connected treatment during the stay, and named responsibility after discharge.